How much cash does Nuvectis Pharma, Inc. generate?

Nuvectis Pharma, Inc. (NVCT) generated -$18.3M in operating cash flow over the trailing twelve months.

Where does Nuvectis Pharma, Inc.'s cash flow data come from?

Every line is extracted from Nuvectis Pharma, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Nuvectis Pharma, Inc. NVCT Cash Flow Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Net income	-$27.16M-34.7%	-$26.44M-39.2%	-$25.38M-31.0%	-$22.07M-4.6%	-$20.16M+9.9%
Stock-based compensation	$6.51M+32.1%	$6.03M+24.2%	$5.7M+15.4%	$5.4M+9.9%	$4.93M+7.2%
Change in accounts payable	$1.87M—	$3.94M—	——	——	——
Change in accrued liabilities	——	——	——	-$308K—	$379K—
Change in other current assets	——	——	——	——	——
Net cash from operating activities	-$18.35M-52.1%	-$16.01M-30.7%	-$14.5M-6.4%	-$12.41M+14.2%	-$12.06M+22.3%
Net cash from investing activities	——	——	——	——	——
Proceeds from issuance of common stock	——	——	——	——	——
Net cash from financing activities	$13.61M-39.4%	$29.11M+150%	$32.77M+275%	$21.09M+164%	$22.46M+15.0%
Net increase (decrease) in cash	——	——	——	——	——
Increase Decrease In Accrued Compensation And Benefits	$1.41M—	$1.35M—	$1.23M—	——	——
Increase (Decrease) in Other Current Assets	——	——	——	——	——
Payments Of Stock Issuance Costs	——	——	——	——	——
Unpaid Issuance Costs Related To Offering	——	——	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Nuvectis Pharma, Inc. generate?: Nuvectis Pharma, Inc. (NVCT) generated -$18.3M in operating cash flow over the trailing twelve months.
Where does Nuvectis Pharma, Inc.'s cash flow data come from?: Every line is extracted from Nuvectis Pharma, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.